-opioid receptor. Research indicates it has a high affinity for these receptors ( nM) while maintaining a significantly lower affinity for -opioid receptors compared to its parent compound.

: Scientific interest in herkinorin largely stems from its functional selectivity. Early studies suggested that it might activate -opioid receptors without significant recruitment of

: Herkinorin acts as a potent and selective agonist at the

-opioid receptor (MOR) agonist. Unlike traditional alkaloids such as morphine, herkinorin is a neoclerodane diterpene and does not contain a basic nitrogen atom, which makes its chemical structure unique among opioid ligands.

: Herkinorin is classified strictly as a research chemical. It is intended only for use in laboratory settings for biochemical and physiological research.

Further scientific literature on the biochemical interactions of herkinorin can be found through academic databases focusing on pharmacology and medicinal chemistry.

: Experimental data has shown that herkinorin can be toxic at certain concentrations, suggesting a narrow margin of safety.

: In laboratory settings using animal models, herkinorin has demonstrated antinociceptive (pain-relieving) effects. These effects appear to be largely restricted to the site of administration rather than acting centrally. Regulatory and Safety Status